NCT01475071 - Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

March 31, 2013

Conditions

Actinic Keratoses

Interventions

DRUG

Metvix and natural daylight PDT

Methyl aminolevulinate, cream 160mg/g.One session at baseline and a second session administration at week 12 for lesions showing non-complete response and new lesions on target area.

DRUG

Metvix and conventional PDT

Methyl aminolevulinate, cream, 160mg/g. One session at baseline and a second session administration at week 12 for lesions showing non-complete response and new lesions on target area.

Trial Locations (6)

Unknown

Galderma Investigational site, Phillip

Galderma Investigational Site, Kogarah

Galderma Investigational site, Sydney

Galderma Investigational site, Westmead

Galderma Investigational site, Woolloongabba

Galderma Investigational site, Carlton